Results 221 to 230 of about 2,529,164 (287)
Abstract University students globally face growing mental health challenges, with ethnic minority (EM) students—both local and international—being particularly vulnerable. Yet, limited research compares their experiences or identifies shared and distinct stressors, especially in non‐Western contexts.
Wang Xinyi, Naubahar Sharif
wiley +1 more source
Sublingual Cyclobenzaprine Approval: Expanding Options for Fibromyalgia Management. [PDF]
Abid MA, Abid MH, Hasan AH, Afzal MD.
europepmc +1 more source
Transaminitis from Duloxetine: Case Report. [PDF]
Galletta G +4 more
europepmc +1 more source
Adherence to CPAP in Randomized Controlled Trials in Obstructive Sleep Apnoea-A Meta-Analysis and Investigation of Predictors. [PDF]
Benning L +4 more
europepmc +1 more source
Recent Advances and Emerging Pharmacotherapeutic Approaches for Central Hypersomnolence Disorders. [PDF]
Aribindi K, Shende TC, Albertson TE.
europepmc +1 more source
Satellite-derived temperature measures miss key physiologically relevant thermal trends on Palauan reefs. [PDF]
Lippert M +7 more
europepmc +1 more source
A historical overview of the cardiovascular safety of sodium oxybate: clinical trials, clinical experience. [PDF]
Kushida CA.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
0638 Stability of Once-Nightly Sodium Oxybate in Alternative Liquid Reconstitution Vehicles
SLEEPAbstract Introduction LUMRYZ™ is a once-nightly formulation of sodium oxybate (ON-SXB) containing both immediate and pH-dependent controlled-release granules designed to be reconstituted in water and administered orally.
Maggie Lavender +6 more
openaire +2 more sources
SLEEP
Abstract Introduction Once-nightly sodium oxybate (ON-SXB; LUMRYZ™) demonstrated efficacy in treating narcolepsy symptoms, including disrupted nighttime sleep (DNS), in the phase 3 REST-ON trial (NCT02720744). This post hoc analysis assessed ON-SXB efficacy on DNS across various participant subgroups.
Yves Dauvilliers +7 more
openaire +2 more sources
Abstract Introduction Once-nightly sodium oxybate (ON-SXB; LUMRYZ™) demonstrated efficacy in treating narcolepsy symptoms, including disrupted nighttime sleep (DNS), in the phase 3 REST-ON trial (NCT02720744). This post hoc analysis assessed ON-SXB efficacy on DNS across various participant subgroups.
Yves Dauvilliers +7 more
openaire +2 more sources
SLEEP
Abstract Introduction The Epworth Sleepiness Scale (ESS) is a commonly used 8-item patient-reported outcome measure for excessive daytime sleepiness. While aggregate data are typically presented, individual domains vary in clinical significance.
Heidy Merius +5 more
openaire +2 more sources
Abstract Introduction The Epworth Sleepiness Scale (ESS) is a commonly used 8-item patient-reported outcome measure for excessive daytime sleepiness. While aggregate data are typically presented, individual domains vary in clinical significance.
Heidy Merius +5 more
openaire +2 more sources

